• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

较高的循环神经酰胺 1-磷酸水平与人类较低的骨密度和较高的骨吸收标志物有关。

Higher circulating sphingosine 1-phosphate levels are associated with lower bone mineral density and higher bone resorption marker in humans.

机构信息

Division of Endocrinology and Metabolism, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea.

出版信息

J Clin Endocrinol Metab. 2012 Aug;97(8):E1421-8. doi: 10.1210/jc.2012-1044. Epub 2012 Jun 7.

DOI:10.1210/jc.2012-1044
PMID:22679064
Abstract

CONTEXT

Several in vivo and in vitro studies suggest that sphingosine-1-phosphate (S1P) is known to act as a coupling factor, to stimulate osteoclastogenesis, to control the migration of osteoclast precursors between the blood and bone, and to stimulate the proliferation, migration, and survival of osteoblasts.

OBJECTIVE

Using the determination of circulating S1P levels, we investigated which kinds of processes may be primarily affected by S1P in humans.

DESIGN AND SETTING

This was a cross-sectional study conducted in two clinical units in Korea.

PARTICIPANTS

Men (n = 86), premenopausal women (n = 94), and postmenopausal women (n = 357) participated in the study.

MAIN OUTCOME MEASURES

We measured S1P levels and their relationships with bone mineral density, biochemical bone turnover markers, and uncoupling indices.

RESULTS

S1P levels were significantly higher in the postmenopausal women than in the premenopausal women and men. High S1P concentrations were significantly associated with low bone mineral density values at some femur sites in the postmenopausal women (P = 0.015 to 0.049), at the lumbar spine in the premenopausal women (P = 0.017), and at all sites in men (P = 0.001 to 0.036) after adjustments with multiple covariates. S1P levels were positively correlated with bone resorption markers (P = 0.003 to 0.049), but not with formation markers in postmenopausal women. Higher S1P levels were associated with lower uncoupling indices (P = <0.001 to 0.048) in postmenopausal women.

CONCLUSION

These findings suggest that S1P may primarily affect bone resorption, resulting in bone loss.

摘要

背景

几项体内和体外研究表明,1-磷酸鞘氨醇(S1P)已知作为偶联因子发挥作用,刺激破骨细胞生成,控制破骨细胞前体在血液和骨骼之间的迁移,并刺激成骨细胞的增殖、迁移和存活。

目的

通过测定循环 S1P 水平,我们研究了 S1P 在人体内可能主要影响哪些过程。

设计和设置

这是一项在韩国两个临床单位进行的横断面研究。

参与者

男性(n=86)、绝经前女性(n=94)和绝经后女性(n=357)参加了这项研究。

主要观察指标

我们测量了 S1P 水平及其与骨密度、生化骨转换标志物和去偶联指数的关系。

结果

绝经后女性的 S1P 水平明显高于绝经前女性和男性。高 S1P 浓度与绝经后女性某些股骨部位(P=0.015 至 0.049)、绝经前女性腰椎(P=0.017)和所有男性部位(P=0.001 至 0.036)的骨密度值降低显著相关,这些部位的骨密度值在经过多种协变量调整后。S1P 水平与骨吸收标志物呈正相关(P=0.003 至 0.049),但与绝经后女性的形成标志物无关。较高的 S1P 水平与较低的去偶联指数相关(P=0.001 至 0.048)。

结论

这些发现表明,S1P 可能主要影响骨吸收,导致骨质流失。

相似文献

1
Higher circulating sphingosine 1-phosphate levels are associated with lower bone mineral density and higher bone resorption marker in humans.较高的循环神经酰胺 1-磷酸水平与人类较低的骨密度和较高的骨吸收标志物有关。
J Clin Endocrinol Metab. 2012 Aug;97(8):E1421-8. doi: 10.1210/jc.2012-1044. Epub 2012 Jun 7.
2
Plasma sphingosine 1-phosphate levels and the risk of vertebral fracture in postmenopausal women.绝经后妇女血浆鞘氨醇 1-磷酸水平与椎体骨折风险。
J Clin Endocrinol Metab. 2012 Oct;97(10):3807-14. doi: 10.1210/jc.2012-2346. Epub 2012 Aug 9.
3
The circulating sphingosine-1-phosphate level predicts incident fracture in postmenopausal women: a 3.5-year follow-up observation study.循环中1-磷酸鞘氨醇水平可预测绝经后女性的骨折发生率:一项3.5年的随访观察研究。
Osteoporos Int. 2016 Aug;27(8):2533-41. doi: 10.1007/s00198-016-3565-z. Epub 2016 Mar 16.
4
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.绝经后期女性骨转换增加是骨质疏松症的主要决定因素。
J Bone Miner Res. 1996 Mar;11(3):337-49. doi: 10.1002/jbmr.5650110307.
5
Effect of menopause and exercise training on plasma apolipoprotein M and sphingosine-1-phosphate.绝经和运动训练对血浆载脂蛋白 M 和鞘氨醇-1-磷酸的影响。
J Appl Physiol (1985). 2019 Jan 1;126(1):214-220. doi: 10.1152/japplphysiol.00527.2018. Epub 2018 Nov 15.
6
Relationships between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese women.中国女性血清脂联素、瘦素浓度与骨密度及骨生化标志物的关系。
Clin Chim Acta. 2010 May 2;411(9-10):771-5. doi: 10.1016/j.cca.2010.02.064. Epub 2010 Feb 23.
7
Circulating estradiol and osteoprotegerin as determinants of bone turnover and bone density in postmenopausal women.循环雌二醇和骨保护素作为绝经后女性骨转换和骨密度的决定因素。
J Clin Endocrinol Metab. 2002 Oct;87(10):4470-5. doi: 10.1210/jc.2002-020396.
8
The effect of sphingosine-1-phosphate on bone metabolism in humans depends on its plasma/bone marrow gradient.1-磷酸鞘氨醇对人体骨代谢的影响取决于其血浆/骨髓梯度。
J Endocrinol Invest. 2016 Mar;39(3):297-303. doi: 10.1007/s40618-015-0364-x. Epub 2015 Jul 29.
9
The Utility of Biomarkers in Osteoporosis Management.生物标志物在骨质疏松症管理中的效用。
Mol Diagn Ther. 2017 Aug;21(4):401-418. doi: 10.1007/s40291-017-0272-1.
10
Bone turnover markers and bone density across the menopausal transition.绝经过渡期间的骨转换标志物与骨密度
J Clin Endocrinol Metab. 1996 Sep;81(9):3366-71. doi: 10.1210/jcem.81.9.8784098.

引用本文的文献

1
Gut microbiota changes in postmenopausal women with low bone density linked to serum amino acid metabolism.骨密度低的绝经后女性肠道微生物群的变化与血清氨基酸代谢有关。
Front Cell Infect Microbiol. 2025 Jul 9;15:1627519. doi: 10.3389/fcimb.2025.1627519. eCollection 2025.
2
Blockade of Gi Signaling Enhances the Anabolic Effect of Parathyroid Hormone in Female Mice.Gi信号通路的阻断增强甲状旁腺激素对雌性小鼠的合成代谢作用。
Calcif Tissue Int. 2025 Jul 16;116(1):98. doi: 10.1007/s00223-025-01409-2.
3
Sphingosine-1-phosphate promotes osteogenesis by stimulating osteoblast growth and neovascularization in a vascular endothelial growth factor-dependent manner.
鞘氨醇-1-磷酸通过刺激血管内皮生长因子依赖性成骨细胞生长和新血管生成来促进成骨作用。
J Bone Miner Res. 2024 Apr 19;39(3):357-372. doi: 10.1093/jbmr/zjae006.
4
Novel Biomarkers of Bone Metabolism.新型骨代谢生物标志物。
Nutrients. 2024 Feb 22;16(5):605. doi: 10.3390/nu16050605.
5
Sphingolipid-Induced Bone Regulation and Its Emerging Role in Dysfunction Due to Disease and Infection.鞘脂诱导的骨调节及其在疾病和感染所致功能障碍中的新作用。
Int J Mol Sci. 2024 Mar 5;25(5):3024. doi: 10.3390/ijms25053024.
6
The Fracture Risk Assessment Tool Probability and Trabecular Bone Score Mediate the Relationship between Sphingosine 1-phosphate Levels and Fracture Risk.骨折风险评估工具概率和小梁骨评分介导了1-磷酸鞘氨醇水平与骨折风险之间的关系。
J Bone Metab. 2023 Nov;30(4):355-364. doi: 10.11005/jbm.2023.30.4.355. Epub 2023 Nov 30.
7
The Ying and Yang of Sphingosine-1-Phosphate Signalling within the Bone.骨内鞘氨醇-1-磷酸信号的阴阳两面
Int J Mol Sci. 2023 Apr 8;24(8):6935. doi: 10.3390/ijms24086935.
8
The role of sphingosine-1-phosphate in bone remodeling and osteoporosis.1-磷酸鞘氨醇在骨重塑和骨质疏松症中的作用。
Bone Res. 2022 Apr 8;10(1):34. doi: 10.1038/s41413-022-00205-0.
9
The Mechanosensory Role of Osteocytes and Implications for Bone Health and Disease States.骨细胞的机械感觉作用及其对骨骼健康和疾病状态的影响。
Front Cell Dev Biol. 2022 Feb 21;9:770143. doi: 10.3389/fcell.2021.770143. eCollection 2021.
10
The Role of Sphingolipid Metabolism in Bone Remodeling.鞘脂代谢在骨重塑中的作用。
Front Cell Dev Biol. 2021 Nov 29;9:752540. doi: 10.3389/fcell.2021.752540. eCollection 2021.